Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Botulism Vaccine”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)WithdrawnNCT01940315
What this trial is testing

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B

Who this might be right for
Botulism
DynPort Vaccine Company LLC, A GDIT Company
Testing effectiveness (Phase 2)Study completedNCT00764634
What this trial is testing

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Who this might be right for
Botulism Vaccine
DynPort Vaccine Company LLC, A GDIT Company 440
Testing effectiveness (Phase 2)Study completedNCT01701999
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

Who this might be right for
Botulism
California Department of Public Health 45
Testing effectiveness (Phase 2)Study completedNCT06112834
What this trial is testing

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Who this might be right for
Botulism
California Department of Public Health 25
Testing effectiveness (Phase 2)Study completedNCT03676634
What this trial is testing

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

Who this might be right for
Botulism
California Department of Public Health 32

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation